Addex Therapeutics LtdADXNNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank29
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P29
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
2024-17.52%
2023-37.74%
2022-57.89%
202134.74%
202033.42%
2019-8.65%
2018114.79%
201744.26%
2016-2.90%
20151.28%